Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer

Acta Biomaterialia

Volumn 28, Issue , 2015, Pages 160-170

  Zhang, Shaojuan ^a   Yang, Ling ^a,b   Ling, Xiaoxi ^a   Shao, Pin ^a   Wang, Xiaolei ^a   Edwards, W Barry ^a   Bai, Mingfeng ^a,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c University of Pittsburgh   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Mitochondria; Photodynamic therapy; Photosensitizer; Translocator protein; TSPO

Indexed keywords

CHEMOTHERAPY; DISEASES; MITOCHONDRIA; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; PROTEINS; TUMORS;

'CURRENT; ENERGY; MINIMALLY INVASIVE; MITOCHONDRIAS; NEGATIVELY CHARGED; PHOTOSENSITISER; TRANSLOCATOR PROTEIN; TRANSLOCATORS;

CELL DEATH;

CISPLATIN; MEMBRANE PROTEIN; PHOTOSENSITIZING AGENT; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CYTOTOXICITY; FEMALE; FLUORESCENCE MICROSCOPY; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; ANIMAL; DRUG EFFECTS; MITOCHONDRION; NEOPLASM; PATHOLOGY; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84947303595     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.09.033     Document Type: Article

References (47)

1. D.E. Dolmans, D. Fukumura, and R.K. Jain Photodynamic therapy for cancer Nat. Rev. Cancer 3 2003 380 387
2. Z. Huang A review of progress in clinical photodynamic therapy Technol. Cancer Res. Treat. 4 2005 283 293
3. J.P. Celli, B.Q. Spring, I. Rizvi, C.L. Evans, K.S. Samkoe, S. Verma, and et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization Chem. Rev. 110 2010 2795 2838
4. C.A. Robertson, D.H. Evans, and H. Abrahamse Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT J. Photochem. Photobiol., B 96 2009 1 8
5. R.R. Allison, G.H. Downie, R. Cuenca, X.H. Hu, C.J. Childs, and C.H. Sibata Photosensitizers in clinical PDT Photodiagn. Photodyn. Ther. 1 2004 27 42
6. M. Ethirajan, Y. Chen, P. Joshi, and R.K. Pandey The role of porphyrin chemistry in tumor imaging and photodynamic therapy Chem. Soc. Rev. 40 2011 340 362
7. A.A. Rosenkranz, D.A. Jans, and A.S. Sobolev Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency Immunol. Cell Biol. 78 2000 452 464
8. N.L. Oleinick, R.L. Morris, and I. Belichenko The role of apoptosis in response to photodynamic therapy: what, where, why, and how Photochem. Photobiol. Sci. 1 2002 1 21
9. M. Mitsunaga, M. Ogawa, N. Kosaka, L.T. Rosenblum, P.L. Choyke, and H. Kobayashi Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules Nat. Med. 17 2011 1685 1691
10. L.F. Yousif, K.M. Stewart, and S.O. Kelley Targeting mitochondria with organelle-specific compounds: strategies and applications ChemBioChem 10 2009 1939 1950
11. S. Wen, D. Zhu, and P. Huang Targeting cancer cell mitochondria as a therapeutic approach Future Med. Chem. 5 2013 53 67
12. R. Hilf Mitochondria are targets of photodynamic therapy J. Bioenerg. Biomembr. 39 2007 85 89
13. Z. Zhao, P.S. Chan, H. Li, K.L. Wong, R.N. Wong, N.K. Mak, and et al. Highly selective mitochondria-targeting amphiphilic silicon(IV) phthalocyanines with axially ligated rhodamine B for photodynamic therapy Inorg. Chem. 51 2012 812 821
14. J. Xu, F. Zeng, H. Wu, C. Hu, and S. Wu Enhanced photodynamic efficiency achieved via a dual-targeted strategy based on photosensitizer/micelle structure Biomacromolecules 15 2014 4249 4259
15. C.J. Austin, J. Kahlert, M. Kassiou, and L.M. Rendina The translocator protein (TSPO): a novel target for cancer chemotherapy Int. J. Biochem. Cell Biol. 45 2013 1212 1216
16. M. Hardwick, D. Fertikh, M. Culty, H. Li, B. Vidic, and V. Papadopoulos Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol Cancer Res. 59 1999 831 842
17. M. Hardwick, L.R. Cavalli, K.D. Barlow, B.R. Haddad, and V. Papadopoulos Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells Cancer Genet. Cytogenet. 139 2002 48 51
18. K. Maaser, P. Grabowski, A.P. Sutter, M. Hopfner, H.D. Foss, H. Stein, and et al. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer Clin. Cancer Res. 8 2002 3205 3209
19. Z. Han, R.S. Slack, W. Li, and V. Papadopoulos Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression J. Recept. Signal Transduct. Res. 23 2003 225 238
20. E. Vlodavsky, and J.F. Soustiel Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival J. Neurooncol. 81 2007 1 7
21. L. Rogers, and M.O. Senge The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy Future Med. Chem. 6 2014 775 792
22. Y. Chen, M. Sajjad, Y. Wang, C. Batt, H.A. Nabi, and R.K. Pandey TSPO 18 kDa (PBR) targeted photosensitizers for cancer imaging (PET) and PDT ACS Med. Chem. Lett. 2 2011 136 141
23. M. Bai, M.B. Rone, V. Papadopoulos, and D.J. Bornhop A novel functional translocator protein ligand for cancer imaging Bioconjug. Chem. 18 2007 2018 2023
24. S.K. Wyatt, H.C. Manning, M. Bai, S.N. Bailey, P. Gallant, G. Ma, and et al. Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer Mol. Imaging Biol. 12 2010 349 358
25. J. Zheng, R. Boisgard, K. Siquier-Pernet, D. Decaudin, F. Dolle, and B. Tavitian Differential expression of the 18 kDa translocator protein (TSPO) by neoplastic and inflammatory cells in mouse tumors of breast cancer Mol. Pharm. 8 2011 823 832
26. H.Y. Kim, X. Wang, B. Wahlberg, and W.B. Edwards Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging Bioconjug. Chem. 25 2014 1311 1322
27. N. Jia, S. Zhang, P. Shao, C. Bagia, J.M. Janjic, Y. Ding, and et al. Cannabinoid CB2 receptor as a new phototherapy target for the inhibition of tumor growth Mol. Pharm. 11 2014 1919 1929
28. M. Sexton, G. Woodruff, E. Cudaback, F.R. Kreitzer, C. Xu, Y.H. Lin, and et al. Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO PLoS ONE 4 2009 e8271
29. P. Golstein, and G. Kroemer Cell death by necrosis: towards a molecular definition Trends Biochem. Sci. 32 2007 37 43
30. V. Papadopoulos, M. Baraldi, T.R. Guilarte, T.B. Knudsen, J.J. Lacapere, P. Lindemann, and et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol. Sci. 27 2006 402 409
31. T. Zhou, Y. Dang, and Y.H. Zheng The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway J. Virol. 88 2014 3474 3484
32. P.X. Petit, M. Goubern, P. Diolez, S.A. Susin, N. Zamzami, and G. Kroemer Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition FEBS Lett. 426 1998 111 116
33. N. Zamzami, and G. Kroemer The mitochondrion in apoptosis: how Pandora's box opens Nat. Rev. Mol. Cell Biol. 2 2001 67 71
34. M. Bai, S.K. Wyatt, Z. Han, V. Papadopoulos, and D.J. Bornhop A novel conjugable translocator protein ligand labeled with a fluorescence dye for in vitro imaging Bioconjug. Chem. 18 2007 1118 1122
35. M.F. Bai, M. Sexton, N. Stella, and D.J. Bornhop MBC94, a conjugable ligand for cannabinoid CB2 receptor imaging Bioconjug. Chem. 19 2008 988 992
36. Z. Wu, P. Shao, S. Zhang, and M. Bai Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors J. Biomed. Opt. 19 2014 36006
37. S. Zhang, N. Jia, P. Shao, Q. Tong, X.Q. Xie, and M. Bai Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor Chem. Biol. 21 2014 338 344
38. R.L. Morris, M.E. Varnes, M.E. Kenney, Y.S. Li, K. Azizuddin, M.W. McEnery, and et al. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4 Photochem. Photobiol. 75 2002 652 661
39. C. Richter, M. Schweizer, A. Cossarizza, and C. Franceschi Control of apoptosis by the cellular ATP level FEBS Lett. 378 1996 107 110
40. Y. Luo, C.K. Chang, and D. Kessel Rapid initiation of apoptosis by photodynamic therapy Photochem. Photobiol. 63 1996 528 534
41. D. Kessel, and Y. Luo Mitochondrial photodamage and PDT-induced apoptosis J. Photochem. Photobiol., B 42 1998 89 95
42. J.C. Goldstein, N.J. Waterhouse, P. Juin, G.I. Evan, and D.R. Green The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant Nat. Cell Biol. 2 2000 156 162
43. M.M. Chamorro, J.D. Regan, L.A. Opperman, and P.R. Kramer Effect of storage media on human periodontal ligament cell apoptosis Dent. Traumatol. 24 2008 11 16
44. S. Zhang, P. Shao, and M. Bai In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe Bioconjug. Chem. 24 2013 1907 1916
45. N.Y. Jia, S.J. Zhang, P. Shao, C. Bagia, J.M. Janjic, Y. Ding, and et al. Cannabinoid CB2 receptor as a new phototherapy target for the inhibition of tumor growth Mol. Pharmaceut. 11 2014 1919 1929
46. E.A. Repasky, S.S. Evans, and M.W. Dewhirst Temperature matters! And why it should matter to tumor immunologists Cancer Immunol. Res. 1 2013 210 216
47. K.L. Rock, and H. Kono The inflammatory response to cell death Annu. Rev. Pathol. 3 2008 99 126